BDBM50026868 2-(1H-indol-3-yl)-N,N-dimethylethanamine::2-(3-indolyl)ethyldimethylamine::3-(2-dimethylaminoethyl)indole::3-[2-(dimethylamino)ethyl]indole::CHEMBL12420::DMT::N,N-dimethyl-1H-indole-3-ethylamine::N,N-dimethyltryptamine::US20240166618, Compound DMT::US20240246911, Compound DMT::US20240317683, Compound DMT::US20250034106, Compound DMT::WO2023019367, Compound DMT

SMILES CN(C)CCc1c[nH]c2c1cccc2

InChI Key InChIKey=DMULVCHRPCFFGV-UHFFFAOYSA-N

Data  87 KI  37 IC50  1 Kd  7 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 132 hits for monomerid = 50026868   

Target5-hydroxytryptamine receptor 2B(Rat)
TBA

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKd:  1.00E+3nMAssay Description:The binding affinity to 5-hydroxytryptamine 2B receptor of rat fundusMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/19/2013
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  22nMAssay Description:Agonist activity at 5HT2A receptor (unknown origin) expressed in HEK293 cells by FLIPR calcium flux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  22nMAssay Description:Agonist activity at 5-HT2A receptor (unknown origin) by calcium flux assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50: <1.00E+4nMAssay Description:The dye is diluted with assay buffer (20mM HEPES in 1x HBSS, PH7.4); Probenecid was added to the final concentration of 5 mM; Hi. Vortexed vigorously...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details
WIPO WO2023019327

Target5-hydroxytryptamine receptor 1A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 190nMAssay Description:Displacement of [3H] 8-OH-DPAT from human recombinant 5-HT1A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 1A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 180nMAssay Description:Displacement of [3H] 8-OH-DPAT from human recombinant 5-HT1A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 1B(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.99E+3nMAssay Description:Displacement of [3H] GR125743 from human recombinant 5-HT1B receptor expressed in human Chem-1 cells incubated for 90 mins by spectrophotometric anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 1B(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 2.42E+3nMAssay Description:Displacement of [3H] GR125743 from human recombinant 5-HT1B receptor expressed in human Chem-1 cells incubated for 90 mins by spectrophotometric anal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 220nMAssay Description:Displacement of [3H] ketanserin from human recombinant 5-HT2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 150nMAssay Description:Displacement of [3H] ketanserin from human recombinant 5-HT2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 410nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT2B receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 480nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT2B receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 390nMAssay Description:Displacement of [3H] mesulergine from human recombinant 5-HT2C receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 530nMAssay Description:Displacement of [3H] mesulergine from human recombinant 5-HT2C receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 5A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 3.32E+3nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT5A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 5A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 3.32E+3nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT5A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.08E+3nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT6 receptor expressed in human HeLa cells incubated for 120 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 6(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.21E+3nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT6 receptor expressed in human HeLa cells incubated for 120 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 7(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 90nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT7 receptor expressed in CHO-K1 cells incubated for 120 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 7(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 120nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT7 receptor expressed in CHO-K1 cells incubated for 120 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1A adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 990nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1a receptor expressed in human Chem-1 cells incubated for 60 mins by spectropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1A adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 580nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1a receptor expressed in human Chem-1 cells incubated for 60 mins by spectropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1B adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 930nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1b receptor expressed in human Chem-1 cells incubated for 60 mins by spectropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1B adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 670nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1b receptor expressed in human Chem-1 cells incubated for 60 mins by spectropho...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1D adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 3.26E+3nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1d receptor expressed in HEK293 cells incubated for 60 mins by spectrophotometr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-1D adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 3.07E+3nMAssay Description:Displacement of [3H] prazosin from human recombinant adrenergic alpha-1d receptor expressed in HEK293 cells incubated for 60 mins by spectrophotometr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2A adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 3.03E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2A adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 2.22E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2A receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2B adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.67E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2b receptor expressed in human CHO-K1 cells incubated for 60 mins by spectro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2B adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.58E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2b receptor expressed in human CHO-K1 cells incubated for 60 mins by spectro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2C adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 6.10E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2c receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAlpha-2C adrenergic receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 9.47E+3nMAssay Description:Displacement of [3H]-rauwolscine from human recombinant adrenergic alpha-2c receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetHistamine H1 receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 340nMAssay Description:Displacement of [3H] pyrilamine from human recombinant histamine H1 receptor expressed in CHO-K1 cells incubated for 180 mins by spectrophotometric a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetHistamine H1 receptor(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 520nMAssay Description:Displacement of [3H] pyrilamine from human recombinant histamine H1 receptor expressed in CHO-K1 cells incubated for 180 mins by spectrophotometric a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 4.40E+3nMAssay Description:Displacement of [125I]-epibatidine from human recombinant nAChR alpha3beta4 receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 4.20E+3nMAssay Description:Displacement of [125I]-epibatidine from human recombinant nAChR alpha3beta4 receptor expressed in CHO-K1 cells incubated for 60 mins by spectrophotom...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of human recombinant MAO-A expressed in insect cells assessed as inhibition of 4-hydroxyquinoline formation using kynuramine as substrate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetAmine oxidase [flavin-containing] A(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 1.18E+3nMAssay Description:Inhibition of human recombinant MAO-A expressed in insect cells assessed as inhibition of 4-hydroxyquinoline formation using kynuramine as substrate ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
TargetSodium-dependent serotonin transporter(Human)
Gilgamesh Pharmaceuticals

US Patent
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 2.96E+3nMAssay Description:The ability of test compounds to block monoamine uptake by SERT was determined using the Neurotransmitter Transporter Uptake Assay Kit manufactured b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/28/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 2.00E+3nMAssay Description:i. Prepared the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 μM st...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  181nMAssay Description:Data from pone.0009019.s006.doc, supplement tables.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2025
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  80nMAssay Description:Data from pone.0009019.s006.doc, supplement tables.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2025
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  440nMAssay Description:Data from pone.0009019.s006.doc, supplement tables.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2025
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataEC50:  28.9nMAssay Description:Data from pone.0009019.s006.doc, supplement tables.More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2025
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataIC50: 500nMAssay Description:i. Prepared the assay buffer following the table below; Reagent Concentration Tris 50 mMCaCl2, 4 mMBSA, 0.1% (w/V) Adjust pH to 7.4 followed by 0.2 μ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/5/2025
Entry Details
Go to US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKi:  33nMAssay Description:Compound was tested for the displacement of [125I]DOI from cloned human 5-hydroxytryptamine 2C receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKi:  40nMAssay Description:Displacement of [3H] ketanserin from human recombinant 5-HT2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Rat)
Stanford University

Curated by PDSP Ki Database
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKi:  42nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2011
Entry Details
PubMed
Target5-hydroxytryptamine receptor 7(Human)
Small Pharma.

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKi:  50nMAssay Description:Displacement of [3H] LSD from human recombinant 5-HT7 receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 120 mins by sp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Usona Institute

Curated by ChEMBL
LigandPNGBDBM50026868(2-(1H-indol-3-yl)-N,N-dimethylethanamine | DMT | N...)
Affinity DataKi:  60nMAssay Description:Displacement of [3H] ketanserin from human recombinant 5-HT2A receptor expressed in CHO-K1 cells assessed as inhibition constant incubated for 60 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/20/2024
Entry Details
PubMed
Displayed 1 to 50 (of 132 total ) | Next | Last >>